Skip to main content

Home/ OARS funding Behavior/ Group items tagged smoking

Rss Feed Group items tagged

MiamiOH OARS

PAR-18-250: Improving Smoking Cessation in Socioeconomically Disadvantaged Populations ... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to provide support for innovative and promising intervention research designed to improve smoking cessation outcomes among socioeconomically disadvantaged populations. Specifically, this FOA is intended to stimulate research efforts aimed at the development of smoking cessation interventions that: 1) are targeted to socioeconomically disadvantaged populations, and 2) could be made scalable for broad population impact Applicants may propose projects that develop and test novel cessation interventions with the potential to be scaled up, as well as projects that focus on enhancing the effectiveness, quality, accessibility, utilization, and cost-effectiveness of currently scaled smoking cessation interventions. This FOA provides funding for up to 2 years for protocol development and early phase, pilot, or exploratory projects.
MiamiOH OARS

Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Tr... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to provide support for research designed to optimize smoking cessation treatment among people living with HIV (PLWH) in the United States (U.S.). Responsive applications must propose research that will be conducted with PLWH and will inform efforts to reduce the incidence of tobacco-related disease and death among PLWH. Research may address the behavioral and sociocultural factors and conditions that are associated with cigarette smoking among PLWH, and may also address smoking-related health disparities among PLWH, considering the heterogeneity across the various subgroups of PLWH.
MiamiOH OARS

COVID-19, Smoking, and Nicotine Research - 0 views

  •  
    The Foundation for a Smoke-free World is seeking to conduct research at the nexus of COVID-19, smoking, and nicotine that will require significant collaboration and research efforts with outside experts and organizations. We seek to advance knowledge of value to science and policy in these areas. The selected organization(s) will implement a range of projects relevant to the global pandemic, including well-designed and comprehensive pre-clinical, clinical, and epidemiological studies, to better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes.
MiamiOH OARS

Interventions and Communication Strategies to Reduce Health Risks of Wildland Fire Smok... - 0 views

  •  
    The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing research that will address behavioral, technical and practical aspects of interventions and communication strategies to reduce exposures and/or health risks of wildland fire smoke.
MiamiOH OARS

RFA-OD-13-010: Tobacco Control Regulatory Research (R21) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing.  Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by NIH using designated funds from the FDA CTP for tobacco regulatory science. Research results from this FOA are expected to generate findings and data that are directly relevant to inform the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.  
MiamiOH OARS

RFA-OD-13-011: Tobacco Control Regulatory Research (R01) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing.  Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by NIH using designated funds from the FDA CTP for tobacco regulatory science. Research results from this FOA are expected to generate findings and data that are directly relevant to inform the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.  
MiamiOH OARS

RFA-OD-13-012: Tobacco Control Regulatory Research (R03) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing.  Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by NIH using designated funds from the FDA CTP for tobacco regulatory science. Research results from this FOA are expected to generate findings and data that are directly relevant to inform the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.  
MiamiOH OARS

Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care ... - 0 views

  •  
    This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that propose to use a common conceptual model to develop behavioral interventions to modify health behaviors and improve health outcomes in patients with comorbid chronic diseases and health conditions. Specifically, this FOA will support research in primary care that uses a multi-disease care management approach to behavioral interventions with high potential impact to improve patient-level health outcomes for individuals with three or more chronic health conditions. The proposed approach must modify behaviors using a common approach rather than administering a distinct intervention for each targeted behavior and/or condition. Diseases and health conditions can include, but are not limited to: mental health disorders (e.g., depression), diabetes, smoking, obesity, chronic pain, alcohol and substance abuse and dependence, chronic obstructive pulmonary disorder, cancer and hypertension.
MiamiOH OARS

NineSights Community - Request for Proposal: 2aTransforming the Future of Tobacco Cess... - 0 views

  •  
    GSK Consumer Healthcare currently is the largest global marketer of nicotine replacement therapies (NRT) for smoking cessation. We serve patients in over 20 countries, including the US, Canada, across Europe, and Australia. GSK Consumer Healthcare strives to transform the future of self-care. We hope to leverage the wisdom of experts within the fields of nicotine and tobacco research to identify areas of critical and emerging unmet needs within the tobacco cessation and reduction space and collaborate with key scientific partners to help deliver upon them.
MiamiOH OARS

Tobacco Regulatory Science (R01 Clinical Trial Optional) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
MiamiOH OARS

RFA-OD-19-019: Tobacco Regulatory Science (R01 Clinical Trial Optional) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.  
MiamiOH OARS

NineSights Community - Request for Proposal: 2aTransforming the Future of Tobacco Cess... - 0 views

  •  
    GSK Consumer Healthcare currently is the largest global marketer of nicotine replacement therapies (NRT) for smoking cessation. We serve patients in over 20 countries, including the US, Canada, across Europe, and Australia.   GSK Consumer Healthcare strives to transform the future of self-care. We hope to leverage the wisdom of experts within the fields of nicotine and tobacco research to identify areas of critical and emerging unmet needs within the tobacco cessation and reduction space and collaborate with key scientific partners to help deliver upon them.
MiamiOH OARS

RFA-OD-17-012: Tobacco Regulatory Science Small Grant Program for New Investigators (R03) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite R03 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
MiamiOH OARS

RFA-OD-17-013: Tobacco Regulatory Science (R01) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.      
MiamiOH OARS

RFA-OD-18-005: Mentored Research Scientist Career Development Award in Tobacco Regulato... - 0 views

  •  
    The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this FOA will be administered by NIH using funds made available through the CTP and the FSPTCA (P.L. 111-31).
MiamiOH OARS

RFA-OD-19-028: Tobacco Regulatory Science (R01 Clinical Trial Optional) - 0 views

  •  
     The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
MiamiOH OARS

Improving the Health and Safety of Transit Workers with Corresponding Impacts on the Bo... - 0 views

  •  
    The objectives of this research are to 1. Define and quantify the health and safety issues facing public transit workers. These include, but are not limited to, behaviors that affect health and safety (sleep, exercise, diet, smoking, seat belt use, alcohol use), chronic diseases (diabetes, cardio-vascular disease, hearing loss), communicable diseases, labor environment, organizational issues (safety climate, organizational programs, policies and procedures, support at work), organization of work (shiftwork, job discretion, job demands), and access to health-promoting activities and healthcare; 2. Using existing information resources, estimate the costs associated with employee health issues; and characterize to the degree possible how these costs are distributed to individuals, transit agencies, and society; 3. Identify and describe scalable and sustainable strategies successfully implemented in transit agencies; and 4. Identify and evaluate potential methods for measuring cost-benefits and cost-effectiveness of these programs to individuals, transit agencies, and society.
MiamiOH OARS

RFA-OD-18-002: Tobacco Regulatory Science (R01 Clinical Trial Optional) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. Also Listed under R21
MiamiOH OARS

RFA-OD-18-001: Tobacco Regulatory Science Small Grant Program for New Investigators (R0... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to support New Investigators in the biomedical, behavioral, and social sciences who are in the early stages of establishing independent careers in tobacco regulatory research. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.
MiamiOH OARS

Maine Cancer Foundation Invites Applications for Projects to Reduce Tobacco Use | RFPs ... - 0 views

  •  
    Lung cancer is responsible for more deaths in Maine than any other cancer, and the state's lung cancer rates are consistently higher than the national average. One in five Maine residents use tobacco, with half identifying as former or current cigarette smokers. With the goal of reducing tobacco use and ultimately reducing the burden of lung cancer in the state, the Maine Cancer Foundation is accepting proposals for projects that seek to reduce the use of tobacco in Maine. Through the program, grants of up to $50,000 a year for up to two years will be awarded in support of new or existing projects. Eligible projects include tobacco cessation for adults; advocacy or policy projects related to tobacco use and/or second-hand smoke; projects that address Maine populations disproportionately impacted by tobacco; and a combination of these. Collaborations between organizations are encouraged.
1 - 20 of 20
Showing 20 items per page